Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 3 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar pchop123 (80.25) Submitted: 2/5/2013 8:57:39 PM : Outperform Start Price: $48.77 SLXP Score: +7.59

the coming positive results should tell the tale

Featured Broker Partners


Advertisement